Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i vs InVision Precision Cardiac Amyloid

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Canon Medical Systems Corporation
VS
by InVision Medical Technology

AI Verdict

Tool A is a CT scanner with integrated AI for general image quality and dose optimization across various medical fields, including cardiology. Tool B is specialized AI software designed to detect cardiac amyloidosis specifically from echocardiogram studies. While both utilize AI in cardiology imaging, Tool A focuses on foundational image acquisition and reconstruction via CT, whereas Tool B provides a diagnostic aid for a specific condition using echocardiography data.

Choose Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i if…

Choose the Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i if your facility requires a versatile, high-performance CT imaging system capable of addressing a broad spectrum of diagnostic needs across cardiology, oncology, and emergency medicine. This tool is ideal for institutions seeking superior image quality, advanced dose optimization, and the ability to accommodate diverse patient populations, from pediatric to bariatric, with integrated AI-assisted reconstruction.

View Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i →

Choose InVision Precision Cardiac Amyloid if…

Choose InVision Precision Cardiac Amyloid if your cardiology department aims to significantly improve the early detection and diagnostic accuracy of cardiac amyloidosis using existing echocardiography workflows. This AI-powered software is specifically designed to analyze transthoracic echocardiogram studies, aiding clinicians in identifying this often underdiagnosed condition to facilitate earlier intervention and better patient outcomes.

View InVision Precision Cardiac Amyloid →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i InVision Precision Cardiac Amyloid
Deployment On-premise (CT System) and mobile-capable configuration for multi-facility deployment. Cloud or on-premise
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

InVision Precision Cardiac Amyloid

Tool B, as a Software as a Medical Device (SaMD), is designed for seamless integration into existing echocardiography lab workflows, aiding clinicians directly in diagnosis. While Tool A's AI enhances image quality for radiologists, Tool B's software-only nature and direct diagnostic aid for a specific condition likely offer a more straightforward and less disruptive integration for its target users.

Clinical Value

InVision Precision Cardiac Amyloid

Tool B offers highly specific and impactful clinical value by targeting cardiac amyloidosis, a life-threatening and often underdiagnosed disease, with an AI algorithm validated by peer-reviewed publication in JAMA Cardiology. While Tool A provides broad, high-quality imaging across many specialties, Tool B's focus on earlier detection and reduction of misdiagnosis for a critical condition, backed by strong evidence, gives it a distinct edge in demonstrable clinical impact for its niche.

Pricing & Value

InVision Precision Cardiac Amyloid

Tool B provides transparent starting pricing at $49/month, making it accessible and allowing for a clear assessment of value. Tool A, being a major capital equipment purchase, requires direct vendor contact for pricing, which lacks transparency and makes a direct value comparison difficult without further engagement.

Enterprise Readiness

Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i

Tool A, a CT scanner from Canon Medical Systems, a major global manufacturer, inherently comes with robust enterprise-level support, service, and established integration capabilities for large hospital systems. Its deployment options (on-premise, modular, mobile) and the company's extensive infrastructure for complex medical hardware signify superior enterprise readiness compared to a specialized software vendor.

Innovation

Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i

Tool A features AiCE-i Deep Learning Reconstruction, a foundational innovation integrated directly into the CT imaging process, significantly improving image quality and dose optimization across all scans. While Tool B's AI for cardiac amyloidosis is innovative in its specific application, AiCE-i represents a broader, more fundamental technological advancement in the core imaging modality itself.

Support & Docs

Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i

As a product from Canon Medical Systems, a large, established global medical device corporation, Tool A benefits from extensive support infrastructure, comprehensive documentation, and a global service network. This level of dedicated, 24/7 support and resources for complex hardware is typically far more extensive than what a specialized software company like InVision Medical Technology can offer.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i InVision Precision Cardiac Amyloid
Product Name Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i InVision Precision Cardiac Amyloid
Product Type CT scanner AI-powered software for echocardiography
Company Canon Medical Systems Corporation InVision Medical Technology Corporation
Primary Clinical Application Comprehensive clinical capabilities for diverse patient needs, from pediatric to bariatric, and supports advanced applications in cardiology, oncology, and emergency medicine. Detection of cardiac amyloidosis, aiding clinicians in diagnosing and assessing patients with heart failure symptoms.
Core Technology Deep Learning Reconstruction (AiCE-i), 40-row CT System (expandable to 80), 160 slices per rotation, PUREViSION Optics, SURECardio Helical Prospective, SEMAR. AI-powered detection, evaluation of transthoracic echocardiogram studies (apical-4-chamber and parasternal-long-axis view videos), evidence-based AI algorithm.
Specific Disease/Condition Detection Not specified Cardiac amyloidosis (both AL and ATTR types)

Videos

Demos, reviews, and walkthroughs featuring Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i and InVision Precision Cardiac Amyloid.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A, the Aquilion Prime SP, is a comprehensive CT scanner with integrated Deep Learning Reconstruction (AiCE-i) for superior image quality and dose optimization across various clinical applications. Tool B, InVision Precision Cardiac Amyloid, is an AI-powered software designed specifically for detecting cardiac amyloidosis from echocardiogram studies.
Tool A's AiCE-i utilizes deep learning to enhance image quality, reduce noise, and optimize dose in CT scans for general diagnostic imaging. In contrast, Tool B's AI is specifically trained to analyze transthoracic echocardiogram studies to aid in the diagnosis and assessment of cardiac amyloidosis.
Tool A offers broad clinical capabilities for diverse patient needs, including advanced applications in cardiology, oncology, and emergency medicine, providing detailed anatomical imaging. Tool B is specifically designed to aid clinicians in the earlier detection and reduction of misdiagnosis for both AL and ATTR Cardiac Amyloidosis in patients with heart failure symptoms.
Tool A, a CT scanner, can perform robust cardiac scanning and offers features like SURECardio Helical Prospective. Tool B specifically detects cardiac amyloidosis from echocardiograms. They address different aspects of cardiac diagnostics and can be complementary, with Tool A providing anatomical detail and Tool B offering specific disease detection from echo studies.
Tool A, the Aquilion Prime SP CT scanner, features a 78 cm gantry bore and a 660-pound patient capacity couch, capable of 160 slices per rotation with 0.35-second scanning for broad imaging needs. Tool B, InVision Precision Cardiac Amyloid, focuses solely on evaluating transthoracic echocardiogram studies (apical-4-chamber and parasternal-long-axis view videos) for cardiac amyloidosis detection.
AI Tool Finder
AI-powered search. Results may not be comprehensive.